Literature DB >> 8718691

The sickle cell painful crisis in adults: phases and objective signs.

S K Ballas1.   

Abstract

The severe sickle cell painful crisis that requires hospitalization in adults typically seems to evolve along four distinct phases: Prodromal, initial, established, and resolving. Each phase may to be associated with certain clinical and laboratory findings. Objective clinical and laboratory signs may not be evident in the initial phase of the crisis especially in the absence of reliable base line steady state data. Several clinical, hematological, biochemical, and rheological changes emerge as the crisis progresses. This sequence of events creates several logistic issues in the care of these patients. The absence of objective findings early in the crisis usually discourages health care providers from repeating such tests and makes some of them suspicious of the authenticity of the painful episode in question. Consequently, an atmosphere of mistrust may develop between the patients and their care providers. This review puts the sickle cell painful crisis in perspective and, based on available data in the literature, shows that it is a dynamic process characterized by several changes during its evolution. It is hoped that this review will dispel some misconceptions about the painful crisis, elucidate its clinical course, and encourage further research to answer the questions it raises.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8718691     DOI: 10.3109/03630269509005824

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  15 in total

1.  Successful Aging with Sickle Cell Disease: Using Qualitative Methods to Inform Theory.

Authors:  Coretta M Jenerette; Gloria Lauderdale
Journal:  J Theory Constr Test       Date:  2008-04-01

Review 2.  Improving Emergency Department-Based Care of Sickle Cell Pain.

Authors:  Jeffrey A Glassberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  Five lessons learned about long-term pain management in adults with sickle cell disease.

Authors:  Joshua J Field
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.

Authors:  Samir K Ballas; Robert L Bauserman; William F McCarthy; Oswaldo L Castro; Wally R Smith; Myron A Waclawiw
Journal:  J Pain Symptom Manage       Date:  2010-12       Impact factor: 3.612

5.  Health-related stigma in young adults with sickle cell disease.

Authors:  Coretta M Jenerette; Cheryl Brewer
Journal:  J Natl Med Assoc       Date:  2010-11       Impact factor: 1.798

6.  Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.

Authors:  Bolanle O P Musa; Geoffrey C Onyemelukwe; Joseph O Hambolu; Aisha I Mamman; Albarka H Isa
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

7.  Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients.

Authors:  Selma Unal; Ozlem Ozdemir; Ahmet Ata Ozcimen; Yesim Oztas
Journal:  Int J Hematol       Date:  2014-12-06       Impact factor: 2.490

8.  Integrin VLA-4 as a PET imaging biomarker of hyper-adhesion in transgenic sickle mice.

Authors:  Lydia A Perkins; Lea Nyiranshuti; Lynda Little-Ihrig; Joseph D Latoche; Kathryn E Day; Qin Zhu; Sina Tavakoli; Prithu Sundd; Enrico M Novelli; Carolyn J Anderson
Journal:  Blood Adv       Date:  2020-09-08

9.  Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.

Authors:  Debra D Pittman; Patrick C Hines; David Beidler; Denis Rybin; Andrew L Frelinger; Alan D Michelson; Ke Liu; Xiufeng Gao; Jennell White; Ahmar U Zaidi; Robert J Charnigo; Michael U Callaghan
Journal:  Blood       Date:  2021-04-15       Impact factor: 22.113

10.  Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy.

Authors:  Oluwatoyin Olatundun Ilesanmi
Journal:  Hematol Rep       Date:  2010-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.